Divestiture

In a move securing benefits for 400 retirees, Laurentian Bank transfers pension duties, reflecting a wider industry trend to reduce risk and simplify.

Amid a major corporate restructure, Atos partners with the World DanceSport Federation, betting on tech to transform the ballroom and secure its market lead.

With its Q4 earnings approaching, all eyes are on Federal Realty to see if its premium retail strategy can sustain its record dividend amid market shifts.

A key partnership is funding hundreds of activities for military children, providing stability and stress relief during deployment and injury recovery.

The opioid treatment specialist projects over $1.1B in revenue, driven by its flagship drug SUBLOCADE and a major strategic overhaul in the U.S.

A major customer delay impacts Ceragon's Q4 revenue, but the company projects significant growth in 2026, banking on a strong backlog and new markets.

A unique Boulder project tackles the housing crisis with modular homes, student builders, and a vision for a sustainable, replicable community model.

Atmus Filtration Technologies acquires Koch Filter for $450M in a major market expansion, while ADTi names a new CEO to lead a sharpened strategic focus.

A major HUD loan sale puts 2,500 occupied homes in the balance, pitting investor profits against the fate of non-borrowing family members.

The renewable firm secures vital grid access for 2.9 GW in the UK and key approvals in Germany, setting the stage for major project divestments.

A strategic bet on ethnic grocery-anchored retail pays off as Arc Capital Partners exits a revitalized Torrance center in a $108.5 million blockbuster deal.

Facing declining revenue but armed with a strong AI vision, Unisys CEO Mike Thomson prepares to address investors at the critical Needham Growth Conference.

Amid rising geopolitical risks, Taiwan's J-Star is exiting China to build an automated factory in the US, a bold move for the micro-cap company.

While US sales numbers declined in 2025, Mazda posted record CPO figures, earned top safety honors, and saw major growth in Canada and Mexico.

Following a period of mixed financials, Neogen appoints new leaders to drive innovation and growth in its critical global food safety division.

With Talya Nevo-Hacohen retiring, veteran Darrin Smith takes the helm as CIO. How will his vision shape Sabra's portfolio in a dynamic healthcare REIT market?

With a hot obesity pipeline and a key neurology asset, Nxera Pharma's J.P. Morgan talk is a crucial test of its plan for global leadership.

A tiny implant stimulating the vagus nerve offers new hope for severe RA. A landmark study now validates this bioelectric therapy for patients out of options.

The renewable energy giant is buying back preferred units, a move showcasing its strong liquidity and sharpening its focus on funding future growth.

Investors eye Aptiv's upcoming Q4 report for clues on its strategy for EV challenges, software delays, and a looming chip shortage in 2026.